Walgreens Boots Alliance's earnings per share without non-recurring items for the
three
months ended in May. 2022 was $0.33.
Its earnings per share without non-recurring items for the trailing twelve months (TTM) ended in May. 2022 was $5.89.
During the past 12 months, Walgreens Boots Alliance's average earnings per share (NRI) Growth Rate was 155.00% per year.
During the past 3 years, the average earnings per share (NRI) Growth Rate was -23.10% per year.
During the past 5 years, the average earnings per share (NRI) Growth Rate was -28.10% per year.
During the past 10 years, the average earnings per share (NRI) Growth Rate was -7.10% per year.
Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the EPS without NRI Growth Rate using Earnings per share without Non-Recurring Items (NRI) data.
The historical rank and industry rank for Walgreens Boots Alliance's EPS without NRI or its related term are showing as below:
WBA'
s 3-Year EPS without NRI Growth Rate Range Over the Past 10 Years
Min: -62.5 Med: 15.1 Max: 129.6
Current: -23.1
During the past 13 years, Walgreens Boots Alliance's highest 3-Year average Earnings Per Share (NRI) Growth Rate was 129.60% per year. The lowest was -62.50% per year. And the median was 15.10% per year.
WBA's 3-Year EPS without NRI Growth Rate is ranked worse than 81.06% of 454
companies
in the Healthcare Providers & Services industry
Industry Median: 11.95
vs WBA: -23.10
Walgreens Boots Alliance's EPS (Diluted) for the
three
months ended in May. 2022 was $0.33.
Its EPS (Diluted) for the trailing twelve months (TTM) ended in May. 2022 was $6.20.
Walgreens Boots Alliance's EPS (Basic) for the
three
months ended in May. 2022 was $0.33.
Its EPS (Basic) for the trailing twelve months (TTM) ended in May. 2022 was $6.20.
Walgreens Boots Alliance EPS without NRI Historical Data
The historical data trend for Walgreens Boots Alliance's EPS without NRI can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
* Premium members only.
Walgreens Boots Alliance Annual Data
Trend
Aug12
Aug13
Aug14
Aug15
Aug16
Aug17
Aug18
Aug19
Aug20
Aug21
EPS without NRI
3.78
5.05
4.13
0.20
2.30
Walgreens Boots Alliance Quarterly Data
Aug17
Nov17
Feb18
May18
Aug18
Nov18
Feb19
May19
Aug19
Nov19
Feb20
May20
Aug20
Nov20
Feb21
May21
Aug21
Nov21
Feb22
May22
EPS without NRI
1.27
0.41
4.13
1.02
0.33
Competitive Comparison
For the Pharmaceutical Retailers subindustry, Walgreens Boots Alliance's EPS without NRI, along with its competitors' market caps and EPS without NRI data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Walgreens Boots Alliance EPS without NRI Distribution
For the Healthcare Providers & Services industry and Healthcare sector, Walgreens Boots Alliance's EPS without NRI distribution charts can be found below:
* The bar in red indicates where Walgreens Boots Alliance's EPS without NRI falls into.
Walgreens Boots Alliance EPS without NRI Calculation
Earnings Per Share (EPS) is the single most important variable used by Wall Street in determining the earnings power of a company. But investors need to be aware that Earnings per Share can be easily manipulated by adjusting depreciation and amortization rate or non-recurring items. That's why GuruFocus lists Earnings per share without Non-Recurring Items, which better reflects the company's underlying performance.
Earnings Per Share without Non-Recurring Items is the amount of earnings without non-recurring items per outstanding share of the company's stock. In calculating earnings per share without non-recurring items, the dividends of preferred stocks and Non Operating Income need to subtracted from the total net income first.
EPS without NRI for the trailing twelve months (TTM) ended in May. 2022 adds up the quarterly data reported by the company within the most recent 12 months, which was $5.89
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Walgreens Boots Alliance (NAS:WBA) EPS without NRI Explanation
A Non Operating Income refers to an entry that appears on a company's financial statements that is unlikely to happen again. It represents a one-time expense involving an unpredictable event and is not part of a firm's normal, day-to-day operations.
Be Aware
Compared with Earnings per share, a company's cash flow is better indicator of the company's earnings power.
If a company's earnings per share is less than cash flow per share over long term, investors need to be cautious and find out why.
Walgreens Boots Alliance EPS without NRI Related Terms
Thank you for viewing the detailed overview of Walgreens Boots Alliance's EPS without NRI provided by GuruFocus.com. Please click on the following links to see related term pages.
Walgreens Boots Alliance is a leading retail pharmacy chain, with over 13,000 stores in 50 states and 9 countries. Walgreens' core strategy involves brick-and-mortar retail pharmacy locations in high-traffic areas, with nearly 80% of the U.S. population living within 5 miles of a store. Currently, the company has a leading market share of the domestic prescription drug market at about 20%. In 2021, the company sold off a majority of its Alliance Healthcare wholesale business to AmerisourceBergen for $6.5 billion, doubling down on its core pharmacy efforts and ventures in strategic growth areas in primary care (VillageMD) and digital offerings. The company also has equity stakes in AmerisourceBergen (29%) and Sinopharm Holding Guoda Drugstores (40%).
My Portfolios
Create New Portfolio
Portfolio Contest
My Gurus
Personalize
Premium Gurus 
0.48(1.18%) Volume: 4,771,528 11:08PM EDT
Email Alerts
Stock PDF
RSS
Website
Filings
Download
Manual of Stocks™ Web APP
NAS:WBA has been successfully added to your 
